Coegin Pharma AB (NGM: COEGIN)

Coegin Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	18.44	5.55	3.82	25.66	16.65
Cash & Short-Term Investments	18.44	5.55	3.82	25.66	16.65
Cash Growth	14.38%	45.39%	-85.13%	54.12%	-
Other Receivables	0.99	0.64	3.13	4.64	2.5
Receivables	0.99	0.64	3.13	4.64	2.5
Prepaid Expenses	0.3	0.02	0.02	0.03	-
Total Current Assets	19.73	6.21	6.97	30.33	19.14
Property, Plant & Equipment	0.26	0.3	0.49	0	0
Other Intangible Assets	8.2	8.92	11.79	-	-
Other Long-Term Assets	2.85	-	10	-	-
Total Assets	31.04	15.43	29.25	30.34	19.15
Accounts Payable	2.06	1.79	2	9.73	1.77
Accrued Expenses	2.58	2.66	1.71	0.22	-
Current Income Taxes Payable	-	-	0.18	-	-
Other Current Liabilities	0.02	4.24	4.34	0.31	0.66
Total Current Liabilities	4.66	8.68	8.23	10.26	2.43
Total Liabilities	4.66	8.68	8.23	10.26	2.43
Common Stock	7.98	4.7	35.33	27.57	23.11
Additional Paid-In Capital	122.31	101.6	94.76	66.38	41.5
Retained Earnings	-	-	-	-75.07	-47.93
Comprensive Income & Other	-103.9	-99.54	-109.08	1.2	0.04
Shareholders' Equity	26.39	6.75	21.01	20.07	16.71
Total Liabilities & Equity	31.04	15.43	29.25	30.34	19.15
Net Cash (Debt)	18.44	5.55	3.82	25.66	16.65
Net Cash Growth	14.38%	45.39%	-85.13%	54.12%	-
Net Cash Per Share	1.90	0.60	0.56	4.32	12.74
Filing Date Shares Outstanding	15.96	9.39	6.94	6.94	1.31
Total Common Shares Outstanding	15.96	9.39	6.94	6.94	1.31
Working Capital	15.07	-2.47	-1.26	20.07	16.71
Book Value Per Share	1.65	0.72	3.03	2.89	12.79
Tangible Book Value	18.19	-2.17	9.22	20.07	16.71
Tangible Book Value Per Share	1.14	-0.23	1.33	2.89	12.79
Machinery	-	0.64	0.68	0.15	0.15

Source: S&P Capital IQ. Standard template. Financial Sources.